<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>44(10)</volume><submitter>Kim HS</submitter><pubmed_abstract>Hypoxia, or low oxygen tension, is a hallmark of the tumor microenvironment. The hypoxia-inducible factor-1α (HIF-1α) subunit plays a critical role in the adaptive cellular response of hypoxic tumor cells to low oxygen tension by activating gene-expression programs that control cancer cell metabolism, angiogenesis, and therapy resistance. Phosphorylation is involved in the stabilization and regulation of HIF-1α transcriptional activity. HIF-1α is activated by several factors, including the mitogen-activated protein kinase (MAPK) superfamily. MAPK phosphatase 3 (MKP-3) is a cytoplasmic dual-specificity phosphatase specific for extracellular signal-regulated kinase 1/2 (Erk1/2). Recent evidence indicates that hypoxia increases the endogenous levels of both MKP-3 mRNA and protein. However, its role in the response of cells to hypoxia is poorly understood. Herein, we demonstrated that small-interfering RNA (siRNA)-mediated knockdown of MKP-3 enhanced HIF-1α (not HIF-2α) levels. Conversely, MKP-3 overexpression suppressed HIF-1α (not HIF-2α) levels, as well as the expression levels of hypoxia-responsive genes (&lt;i>LDHA&lt;/i>, &lt;i>CA9&lt;/i>, &lt;i>GLUT-1&lt;/i>, and &lt;i>VEGF&lt;/i>), in hypoxic colon cancer cells. These findings indicated that MKP-3, induced by HIF-1α in hypoxia, negatively regulates HIF-1α protein levels and hypoxia-responsive genes. However, we also found that long-term hypoxia (&lt;sub>>&lt;/sub>12 h) induced proteasomal degradation of MKP-3 in a lactic acid-dependent manner. Taken together, MKP-3 expression is modulated by the hypoxic conditions prevailing in colon cancer, and plays a role in cellular adaptation to tumor hypoxia and tumor progression. Thus, MKP-3 may serve as a potential therapeutic target for colon cancer treatment.</pubmed_abstract><journal>Molecules and cells</journal><pagination>710-722</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8560588</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Biphasic Regulation of Mitogen-Activated Protein Kinase Phosphatase 3 in Hypoxic Colon Cancer Cells.</pubmed_title><pmcid>PMC8560588</pmcid><pubmed_authors>Lee MS</pubmed_authors><pubmed_authors>Kang YH</pubmed_authors><pubmed_authors>Lee J</pubmed_authors><pubmed_authors>Kim HS</pubmed_authors><pubmed_authors>Kim DB</pubmed_authors><pubmed_authors>Han SR</pubmed_authors><pubmed_authors>Park S</pubmed_authors><pubmed_authors>Ko H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Biphasic Regulation of Mitogen-Activated Protein Kinase Phosphatase 3 in Hypoxic Colon Cancer Cells.</name><description>Hypoxia, or low oxygen tension, is a hallmark of the tumor microenvironment. The hypoxia-inducible factor-1α (HIF-1α) subunit plays a critical role in the adaptive cellular response of hypoxic tumor cells to low oxygen tension by activating gene-expression programs that control cancer cell metabolism, angiogenesis, and therapy resistance. Phosphorylation is involved in the stabilization and regulation of HIF-1α transcriptional activity. HIF-1α is activated by several factors, including the mitogen-activated protein kinase (MAPK) superfamily. MAPK phosphatase 3 (MKP-3) is a cytoplasmic dual-specificity phosphatase specific for extracellular signal-regulated kinase 1/2 (Erk1/2). Recent evidence indicates that hypoxia increases the endogenous levels of both MKP-3 mRNA and protein. However, its role in the response of cells to hypoxia is poorly understood. Herein, we demonstrated that small-interfering RNA (siRNA)-mediated knockdown of MKP-3 enhanced HIF-1α (not HIF-2α) levels. Conversely, MKP-3 overexpression suppressed HIF-1α (not HIF-2α) levels, as well as the expression levels of hypoxia-responsive genes (&lt;i>LDHA&lt;/i>, &lt;i>CA9&lt;/i>, &lt;i>GLUT-1&lt;/i>, and &lt;i>VEGF&lt;/i>), in hypoxic colon cancer cells. These findings indicated that MKP-3, induced by HIF-1α in hypoxia, negatively regulates HIF-1α protein levels and hypoxia-responsive genes. However, we also found that long-term hypoxia (&lt;sub>>&lt;/sub>12 h) induced proteasomal degradation of MKP-3 in a lactic acid-dependent manner. Taken together, MKP-3 expression is modulated by the hypoxic conditions prevailing in colon cancer, and plays a role in cellular adaptation to tumor hypoxia and tumor progression. Thus, MKP-3 may serve as a potential therapeutic target for colon cancer treatment.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2024-11-07T09:22:44.86Z</modification><creation>2022-02-11T12:48:25.736Z</creation></dates><accession>S-EPMC8560588</accession><cross_references><pubmed>34711689</pubmed><doi>10.14348/molcells.2021.0093</doi></cross_references></HashMap>